Back pain relief often begins with small daily changes

Gentle movement usually helps more than bed rest

Short walks are a sound place to begin. Break up long spells in a chair, and use a firm seat that lets your feet rest flat. If one motion keeps causing a catch, shorten the range for now.

Heat can relax a stiff back, while a cold pack may feel better after a new strain. Use either for a brief spell with cloth between the pack and your skin. Don’t fall asleep on a heating pad.

Your pace should feel manageable.

Add time or effort in small amounts after several steady days. If a task causes a clear flare, do less next time instead of stopping all movement. Sleep, water, and regular meals also help you handle a sore day.

A visit helps when daily life keeps shrinking

It is worth getting checked when the ache lasts, returns often, or keeps you from sleep and errands. Your provider will ask how it began and whether it reaches a leg. The provider may ask you to bend, walk, or press against a hand.

The exam guides the next step. That may be home exercise, physical therapy, medicine, or a closer look at a nerve. Surgery isn’t the usual answer for a simple sore back. It can matter when weakness grows or a clear cause needs it.

Make a note before you go: which movements help, and which do not? Take a current list of medicines plus any old scan report. QC Kinetix offers non-surgical regenerative treatments for back soreness after a medical provider reviews your history and goals.

Sources

1. A 2025 Cochrane overview of 31 Cochrane reviews covering 644 trials and 97,183 adults found that exercise therapies probably reduce chronic low back pain by 15.2 points on a 0-100 scale versus no treatment or usual care and improve function by 6.8 points, that multidisciplinary therapies probably produce a medium pain reduction, that acupuncture probably improves function only slightly versus sham, that traction is probably no different from sham traction, and that spinal manipulation probably makes no difference to function versus placebo in acute low back pain.

   Rizzo RR, Cashin AG, Wand BM, et al. — Non-pharmacological and non-surgical treatments for low back pain in adults: an overview of Cochrane reviews.. Cochrane Database of Systematic Reviews, 2025. DOI: 10.1002/14651858.CD014691.pub2.

2. High-quality evidence from 13 randomised trials shows paracetamol (acetaminophen) is INEFFECTIVE for low back pain: the weighted mean difference against placebo was -0.5 points on a 0-100 pain scale, with no effect on disability or quality of life, and patients taking it were nearly four times more likely to have abnormal liver function tests.

   Machado GC, Maher CG, Ferreira PH, et al. — Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials.. BMJ, 2015. DOI: 10.1136/bmj.h1225.

3. A meta-analysis of 35 placebo-controlled randomised trials found NSAIDs reduce spinal pain and disability, but by an amount below the threshold for clinical importance: six people must be treated with an NSAID rather than placebo for one additional person to achieve clinically important pain reduction, and NSAIDs raised the risk of gastrointestinal reactions 2.5-fold. The authors conclude that no simple analgesic provides clinically important effects for spinal pain over placebo.

   Machado GC, Maher CG, Ferreira PH, et al. — Non-steroidal anti-inflammatory drugs for spinal pain: a systematic review and meta-analysis.. Annals of the Rheumatic Diseases, 2017. DOI: 10.1136/annrheumdis-2016-210597.

4. The SPACE trial randomised 240 patients with moderate-to-severe chronic back pain or hip/knee osteoarthritis pain to an opioid or a non-opioid medication strategy for 12 months. Opioids were not superior on pain-related function, pain intensity was significantly BETTER in the non-opioid group, and medication-related adverse symptoms were significantly more common with opioids. The authors state the results do not support initiating opioid therapy for chronic back pain.

   Krebs EE, Gravely A, Nugent S, et al. — Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial.. JAMA, 2018. DOI: 10.1001/jama.2018.0899.

5. The Cochrane review of acupuncture for chronic non-specific low back pain included 33 studies and 8,270 participants. Against SHAM acupuncture the pain difference was 9.22 points on a 0-100 scale - below the review's 15-point clinical threshold - and back-specific function was no better than sham. Against no treatment acupuncture produced a clinically important 20.32-point pain reduction. The gap between those two comparisons is the size of the ritual effect.

   Mu J, Furlan AD, Lam WY, et al. — Acupuncture for chronic nonspecific low back pain.. Cochrane Database of Systematic Reviews, 2020. DOI: 10.1002/14651858.CD013814.

6. A meta-analysis of 47 randomised trials and 9,211 participants found spinal manipulative therapy produces effects SIMILAR to other recommended therapies for chronic low back pain and small, not clinically better, effects than non-recommended therapies. The evidence against sham manipulation was low to very low quality and should be considered uncertain. Most observed adverse events were transient and musculoskeletal.

   Rubinstein SM, de Zoete A, van Middelkoop M, et al. — Benefits and harms of spinal manipulative therapy for the treatment of chronic low back pain: systematic review and meta-analysis of randomised controlled trials.. BMJ, 2019. DOI: 10.1136/bmj.l689.

7. The Mint trials randomised 681 patients with chronic low back pain and a POSITIVE diagnostic block - facet, sacroiliac, or a combination - to radiofrequency denervation plus a standardised exercise programme or the exercise programme alone. The prespecified minimal clinically important difference was 2 points. The actual differences at three months were 0.18, 0.71 and 0.99 points. The authors conclude the findings 'do not support the use of radiofrequency denervation to treat chronic low back pain from these sources.'

   Juch JNS, Maas ET, Ostelo RWJG, et al. — Effect of Radiofrequency Denervation on Pain Intensity Among Patients With Chronic Low Back Pain: The Mint Randomized Clinical Trials.. JAMA, 2017. DOI: 10.1001/jama.2017.7918.

8. The 2023 Cochrane review of spinal cord stimulation for low back pain included 13 studies and 699 participants and found NO study evaluated pain at 12 months or beyond. At six months, moderate-certainty evidence from the single available placebo-controlled trial showed SCS probably does not improve back or leg pain, function or quality of life versus placebo. In one study 13 of 42 people (31%) required revision surgery within 24 months. The authors state the data 'do not support the use of SCS to manage low back pain outside a clinical trial.'

   Traeger AC, Gilbert SE, Harris IA, Maher CG — Spinal cord stimulation for low back pain.. Cochrane Database of Systematic Reviews, 2023. DOI: 10.1002/14651858.CD014789.pub2.

9. A double-blind trial randomised 78 people with painful, MRI-confirmed, unhealed osteoporotic vertebral fractures to vertebroplasty or a SHAM procedure. Vertebroplasty produced no significant advantage on any measured outcome at any time point, while both groups improved substantially. The lesson generalises well beyond vertebroplasty: a procedure that reliably makes patients feel better in an open trial can be indistinguishable from a convincing fake once the comparison is blinded.

   Buchbinder R, Osborne RH, Ebeling PR, et al. — A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures.. New England Journal of Medicine, 2009. DOI: 10.1056/NEJMoa0900429.

10. A 2026 double-blind randomised superiority trial of 76 patients with facet joint syndrome found PRP was NOT superior to corticosteroid: at six months only 6 PRP patients and 5 corticosteroid patients had reached the 50% pain-improvement endpoint, and there were no statistically significant differences in pain at 3, 6 or 12 months. The authors conclude the results 'do not support the use of PRP injections for facet joint syndrome.'

    Geoffroy M, Beissat M, Kanagaratnam L, Ackah Miezan S, Salmon JH — Platelet-rich plasma versus corticosteroids in facet joint syndrome: A controlled, randomized, double-blind study.. Joint Bone Spine, 2026. DOI: 10.1016/j.jbspin.2025.106001.

11. A double-blinded randomised trial at two university spine centres, using stringent inclusion criteria (>80% relief on a diagnostic block) and fluoroscopic guidance, compared sacroiliac joint PRP with sacroiliac steroid in 26 patients. Both groups improved, but the STEROID group reported lower pain and had significantly more responders (>=50% improvement) at one and three months than the PRP group. This is the best-designed sacroiliac comparison available and it favours the cheap conventional option.

    Chen AS, Solberg J, Smith C, et al. — Intra-Articular Platelet Rich Plasma vs Corticosteroid Injections for Sacroiliac Joint Pain: A Double-Blinded, Randomized Clinical Trial.. Pain Medicine, 2022. DOI: 10.1093/pm/pnab332.

12. The FDA states verbatim that stem cell products, stromal vascular fraction, umbilical cord blood, Wharton's jelly, amniotic fluid and exosome products have NOT been 'approved for the treatment of any orthopedic condition, such as osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain, or shoulder pain.' No stem cell product is approved in the United States for any orthopedic use: the only ones with FDA approval at all are blood-forming cells derived from umbilical cord blood, approved solely for disorders of blood production, and there are currently no FDA-approved exosome products.

    U.S. Food and Drug Administration — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes.. FDA.gov, 2025.